Kwality Pharmaceuticals Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Kwality Pharmaceuticals Limited Pharmaceutical Export Portfolio Dataset — 20 Products, $5.6M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Kwality Pharmaceuticals Limited — Pharmaceutical Exporter Profile (2026) | 20 Products, $5.6M Trade | TransData Nexus

Kwality Pharmaceuticals Limited

Indian Pharmaceutical Exporter · Respiratory & OTC Specialist · $5.6M Total Trade · DGFT Verified

Kwality Pharmaceuticals Limited is an Indian pharmaceutical exporter with a total trade value of $5.6M across 20 products in 11 therapeutic categories. Based on 332 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Caffeine ($1.4M), Hydrocortisone ($1.3M), Docetaxel ($900.0K).

Kwality Pharmaceuticals Limited — Export Portfolio & Destination Treemap

Kwality Pharmaceuticals Limited pharmaceutical export portfolio — 20 products across 11 therapeutic categories. Source: Indian Customs (DGFT).

Who is Kwality Pharmaceuticals Limited? — Company Overview & Market Position

Kwality Pharmaceuticals Limited, established on May 4, 1983, by Mr. Ramesh Arora, is a prominent Indian manufacturer and exporter of finished pharmaceutical formulations. The company is headquartered in Amritsar, Punjab, India, with its registered office located at 6th Mile Stone, Village Nag Kalan, Majitha Road, Amritsar. Kwality Pharmaceuticals is listed on the Bombay Stock Exchange under the ticker symbol 539997. The company employs approximately 997 individuals, reflecting its substantial presence in the pharmaceutical manufacturing sector. For more information, their official website is www.kwalitypharma.com.

What Does Kwality Pharmaceuticals Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Caffeine$1.4M 2Hydrocortisone$1.3M

Product Portfolio — Top 20 by Export Value

Kwality Pharmaceuticals Limited exports 20 pharmaceutical products across 11 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Caffeine	Respiratory & OTC	$1.4M	27	1.3%	12
2	Hydrocortisone	Corticosteroids	$1.3M	57	2.0%	9
3	Docetaxel	Oncology	$900.0K	18	2.3%	3
4	Imipenem	Advanced Antibiotics	$324.4K	18	1.0%	9
5	Amikacin	Advanced Antibiotics	$269.2K	31	1.3%	12
6	Cyclophosphamide	Oncology	$235.6K	19	1.2%	7
7	Empagliflozin	Diabetes & Endocrine	$205.3K	24	3.1%	9
8	Ifosfamide	Advanced Oncology	$177.0K	9	7.2%	4
9	Morphine	Analgesics & Antipyretics	$164.0K	28	0.9%	6
10	Bleomycin	Advanced Oncology	$129.5K	6	2.3%	10
11	Letrozole	Advanced Oncology	$115.5K	18	0.4%	15
12	Sulfasalazine	Gastrointestinal	$113.6K	7	3.5%	7
13	Tamoxifen	Advanced Oncology	$73.7K	7	0.5%	10
14	Vincristine	Oncology	$55.2K	9	2.7%	9
15	Fentanyl	Analgesics & Antipyretics	$51.4K	12	1.4%	10
16	Benzylpenicillin	Advanced Antibiotics	$43.7K	9	1.1%	8
17	Linagliptin	Advanced Diabetes Medications	$43.5K	12	1.1%	9
18	Vinblastine	Oncology	$34.7K	6	4.6%	6
19	Prednisone	Respiratory	$20.9K	8	0.1%	14
20	Ribavirin	Antivirals	$15.7K	7	2.4%	3

Kwality Pharmaceuticals Limited exports 20 pharmaceutical products across 11 therapeutic categories with a total export value of $5.6M. The top category is Respiratory & OTC (24.0% of portfolio), followed by Corticosteroids (23.2%), indicating a concentrated portfolio with the top 5 products accounting for 73.7% of total export value.

Kwality Pharmaceuticals Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Kwality Pharmaceuticals operates state-of-the-art manufacturing facilities in Amritsar, Punjab, and Himachal Pradesh, India. The Amritsar plant specializes in generic formulations, including tablets, capsules, oral liquids, suspensions, injections, creams, drops, and suppositories. The Himachal Pradesh unit focuses on oncology products, adhering to EU standards for cytotoxic drugs. Both facilities are equipped with modern equipment and automation systems, ensuring compliance with global quality standards.

3Key Leadership

Mr. Ramesh Arora serves as the Managing Director of Kwality Pharmaceuticals Limited, providing visionary leadership since the company's inception. Mr. Aditya Arora, a commerce graduate, has quickly grasped the intricacies of the pharmaceutical business and has taken charge of spearheading the organization's transition towards regulated markets. Other key executives include Mr. Ajay Arora, Director, who oversees manufacturing planning and operations, and Mrs. Anu Arora, Director, who heads the company's HR department.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Kwality Pharmaceuticals Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Kwality Pharmaceuticals has made significant strides in regulated markets, obtaining approvals from various global regulatory authorities. The company has received WHO-GMP, EU-GMP, and PIC/S certifications, affirming its adherence to international quality standards. Additionally, Kwality Pharmaceuticals has secured approvals from the General Directorate of Medicines, Supplies and Drugs (DIGEMID) in Peru for its Generic, Injectable & OSD (Unit-1 in Amritsar) and for Oncology, Injectable & OSD (Unit-3 in Himachal Pradesh). These certifications and approvals facilitate the company's market access in the US, EU, UK, Australia, and Japan.

2Emerging Markets

Kwality Pharmaceuticals has expanded its presence in emerging markets across Africa, Latin America, and Southeast Asia. The company's adherence to WHO-GMP standards has enabled it to gain acceptance in these regions, where regulatory compliance is crucial. By obtaining approvals from authorities such as DIGEMID in Peru, Kwality Pharmaceuticals has enhanced its ability to supply high-quality formulations to these markets.

3Geographic Strategy

Kwality Pharmaceuticals Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Kwality Pharmaceuticals has achieved FDA facility registrations, reflecting its compliance with stringent US regulatory standards. The company has also filed multiple Abbreviated New Drug Applications (ANDAs) and Drug Master Files (DMFs), indicating its active participation in the US market. Inspection histories are favorable, with no significant observations reported. These accomplishments underscore Kwality Pharmaceuticals' commitment to maintaining high-quality standards and regulatory compliance in the US market.

2WHO & EU GMP

Kwality Pharmaceuticals has obtained WHO-GMP and EU-GMP certifications, demonstrating its adherence to international quality standards. These certifications are crucial for market access in regulated regions and reflect the company's commitment to producing high-quality pharmaceutical formulations.

3CDSCO & Indian Regulatory

In India, Kwality Pharmaceuticals holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), ensuring compliance with national regulatory requirements. The company has also obtained approvals from state drug controllers and export No Objection Certificates (NOCs), facilitating its export activities. These regulatory clearances affirm Kwality Pharmaceuticals' commitment to maintaining high-quality standards and adhering to Indian regulatory norms.

Kwality Pharmaceuticals Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Kwality Pharmaceuticals operates in a competitive landscape with several key players in the pharmaceutical manufacturing sector. While specific market share data is not available, the company's adherence to international quality standards and its diverse product portfolio position it favorably in the market. The company's focus on complex molecules and its expansion into regulated markets provide a competitive edge in the industry.

2Key Differentiators

Kwality Pharmaceuticals' key differentiators include its commitment to quality, as evidenced by certifications such as WHO-GMP and EU-GMP, and its focus on complex molecule manufacturing. The company's diversified product portfolio, including oncology, anti-retroviral, and various dosage forms, caters to a wide range of therapeutic areas. Additionally, Kwality Pharmaceuticals' expansion into regulated markets and its adherence to international standards set it apart from competitors.

3Strategic Position

Kwality Pharmaceuticals is strategically positioned as a manufacturer of finished pharmaceutical formulations, with a focus on complex molecules. The company's expansion into regulated markets and its commitment to quality and innovation underscore its strategic direction. Looking ahead, Kwality Pharmaceuticals aims to continue its growth trajectory by leveraging its strengths in manufacturing and regulatory compliance to meet global healthcare needs.

Buyer Due Diligence Brief — Evaluating Kwality Pharmaceuticals Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Kwality Pharmaceuticals has a strong track record in pharmaceutical manufacturing, with a diverse product portfolio and a commitment to quality. The company's export volume and consistency are supported by its adherence to international quality standards and regulatory compliance. Reliability indicators include certifications such as WHO-GMP and EU-GMP, as well as approvals from various global regulatory authorities.

2Certifications to Verify

Importers should verify the following certifications when considering Kwality Pharmaceuticals as a supplier:

FDA Facility Registration: Confirm the company's registration status with the US Food and Drug Administration.

WHO-GMP Certification: Verify the company's compliance with World Health Organization Good Manufacturing Practices.

EU-GMP Certification: Ensure the company adheres to European Union Good Manufacturing Practices.

Frequently Asked Questions — Kwality Pharmaceuticals Limited

How many pharmaceutical products does Kwality Pharmaceuticals Limited export from India?

Kwality Pharmaceuticals Limited exports 20 pharmaceutical products across 11 therapeutic categories. The top exports are Caffeine ($1.4M), Hydrocortisone ($1.3M), Docetaxel ($900.0K), Imipenem ($324.4K), Amikacin ($269.2K). Total export value is $5.6M.

What is Kwality Pharmaceuticals Limited's total pharmaceutical export value?

Kwality Pharmaceuticals Limited's total pharmaceutical export value is $5.6M, based on 332 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Kwality Pharmaceuticals Limited cover?

Kwality Pharmaceuticals Limited exports across 11 therapeutic categories. The largest are Respiratory & OTC (24.0%, 1 products), Corticosteroids (23.2%, 1 products), Oncology (21.8%, 4 products).

Get Full Kwality Pharmaceuticals Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.